Insider Transactions (Form 4)
Last 7 days · 3,609 transactions ·
543 issuers
· Buys: 1,344
· Sells: 2,265
Only recent data is shown. Form 144 is not insider-trade execution data and is listed in SEC filings pages.
Filed = SEC submission date.
Page 1 of 37
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other
| Filed | Ticker | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 15, 2026 | PSNL | Chen Richard | President and CMO | M | D (Sell) | 100,000.0 | 0.0 | 0.0 | 0.0 | View |
| Jul 15, 2026 | PSNL | Chen Richard | President and CMO | S | D (Sell) | 100,000.0 | 15.15 | 1,515,000.0 | 173,880.0 | View |
| Jul 15, 2026 | PSNL | Chen Richard | President and CMO | M | A (Buy) | 100,000.0 | 2.44 | 244,000.0 | 273,880.0 | View |
| Jul 15, 2026 | MLYS | Rodman David Malcom | Chief Medical Officer | S | D (Sell) | 6,349.0 | 26.6112 | 168,954.51 | 51,384.0 | View |
| Jul 15, 2026 | FULC | TANG KEVIN | — | P | A (Buy) | 107,377.0 | 3.56 | 382,262.12 | 6,913,329.0 | View |
| Jul 15, 2026 | NET | Zatlyn Michelle | President and Board Co-Chair | C | D (Sell) | 33,003.0 | 0.0 | 0.0 | 0.0 | View |
| Jul 15, 2026 | NET | Zatlyn Michelle | President and Board Co-Chair | M | A (Buy) | 33,003.0 | 0.0 | 0.0 | 33,003.0 | View |
| Jul 15, 2026 | NET | Zatlyn Michelle | President and Board Co-Chair | M | D (Sell) | 33,003.0 | 0.0 | 0.0 | 1,188,108.0 | View |
| Jul 15, 2026 | NET | Zatlyn Michelle | President and Board Co-Chair | S | D (Sell) | 756.0 | 289.8756 | 219,145.95 | 47,425.0 | View |
| Jul 15, 2026 | NET | Zatlyn Michelle | President and Board Co-Chair | S | D (Sell) | 6,912.0 | 289.0675 | 1,998,034.56 | 48,181.0 | View |
| Jul 15, 2026 | NET | Zatlyn Michelle | President and Board Co-Chair | S | D (Sell) | 1,185.0 | 287.5619 | 340,760.85 | 55,093.0 | View |
| Jul 15, 2026 | NET | Zatlyn Michelle | President and Board Co-Chair | S | D (Sell) | 8,444.0 | 286.6582 | 2,420,541.84 | 56,278.0 | View |
| Jul 15, 2026 | NET | Zatlyn Michelle | President and Board Co-Chair | S | D (Sell) | 7,201.0 | 285.805 | 2,058,081.81 | 64,722.0 | View |
| Jul 15, 2026 | NET | Zatlyn Michelle | President and Board Co-Chair | S | D (Sell) | 5,248.0 | 284.6833 | 1,494,017.96 | 71,923.0 | View |
| Jul 15, 2026 | NET | Zatlyn Michelle | President and Board Co-Chair | S | D (Sell) | 3,257.0 | 283.6889 | 923,974.75 | 77,171.0 | View |
| Jul 15, 2026 | NET | Zatlyn Michelle | President and Board Co-Chair | C | A (Buy) | 33,003.0 | — | — | 80,428.0 | View |
| Jul 15, 2026 | ORKA | Goncalves Joana | Chief Medical Officer | M | D (Sell) | 3,500.0 | 0.0 | 0.0 | 171,992.0 | View |
| Jul 15, 2026 | ORKA | Goncalves Joana | Chief Medical Officer | M | D (Sell) | 3,500.0 | 0.0 | 0.0 | 200,563.0 | View |
| Jul 15, 2026 | ORKA | Goncalves Joana | Chief Medical Officer | S | D (Sell) | 300.0 | 87.2533 | 26,175.99 | 32,718.0 | View |
| Jul 15, 2026 | ORKA | Goncalves Joana | Chief Medical Officer | S | D (Sell) | 3,803.0 | 86.6764 | 329,630.35 | 33,018.0 | View |
| Jul 15, 2026 | ORKA | Goncalves Joana | Chief Medical Officer | S | D (Sell) | 2,497.0 | 85.8572 | 214,385.43 | 36,821.0 | View |
| Jul 15, 2026 | ORKA | Goncalves Joana | Chief Medical Officer | S | D (Sell) | 400.0 | 84.365 | 33,746.0 | 39,318.0 | View |
| Jul 15, 2026 | ORKA | Goncalves Joana | Chief Medical Officer | M | A (Buy) | 3,500.0 | 7.8 | 27,300.0 | 39,718.0 | View |
| Jul 15, 2026 | ORKA | Goncalves Joana | Chief Medical Officer | M | A (Buy) | 3,500.0 | 6.84 | 23,940.0 | 36,218.0 | View |
| Jul 15, 2026 | MAX | Nonko Eugene | — | S | D (Sell) | 9,524.0 | 14.1406 | 134,675.07 | 1,089,684.0 | View |
| Jul 15, 2026 | MAX | Nonko Eugene | — | S | D (Sell) | 4,952.0 | 14.0259 | 69,456.26 | 890,574.0 | View |
| Jul 15, 2026 | MAX | Yi Steven | See Remarks | S | D (Sell) | 114,292.0 | 14.1665 | 1,619,117.62 | 2,554,480.0 | View |
| Jul 15, 2026 | MAX | Cramer Keith | Chief Revenue Officer | S | D (Sell) | 13,000.0 | 14.1919 | 184,494.7 | 267,528.0 | View |
| Jul 15, 2026 | NUVL | Meyers Michael L. | — | D | D (Sell) | 4,147.0 | — | — | 0.0 | View |
| Jul 15, 2026 | NUVL | Meyers Michael L. | — | D | D (Sell) | 3,789.0 | — | — | 0.0 | View |
| Jul 15, 2026 | NUVL | Meyers Michael L. | — | D | D (Sell) | 15,000.0 | — | — | 0.0 | View |
| Jul 15, 2026 | NUVL | Meyers Michael L. | — | D | D (Sell) | 40,000.0 | — | — | 0.0 | View |
| Jul 15, 2026 | NUVL | Meyers Michael L. | — | D | D (Sell) | 8,361.0 | — | — | 0.0 | View |
| Jul 15, 2026 | NUVL | Meyers Michael L. | — | D | D (Sell) | 3,444.0 | — | — | 0.0 | View |
| Jul 15, 2026 | NUVL | Meyers Michael L. | — | U | D (Sell) | 5,146.0 | 124.0 | 638,104.0 | 0.0 | View |
| Jul 15, 2026 | NUVL | Balcom Alexandra | Chief Financial Officer | D | D (Sell) | 17,500.0 | — | — | 0.0 | View |
| Jul 15, 2026 | NUVL | Balcom Alexandra | Chief Financial Officer | D | D (Sell) | 37,500.0 | — | — | 0.0 | View |
| Jul 15, 2026 | NUVL | Balcom Alexandra | Chief Financial Officer | D | D (Sell) | 33,646.0 | — | — | 0.0 | View |
| Jul 15, 2026 | NUVL | Balcom Alexandra | Chief Financial Officer | D | D (Sell) | 84,200.0 | — | — | 0.0 | View |
| Jul 15, 2026 | NUVL | Balcom Alexandra | Chief Financial Officer | D | D (Sell) | 22,933.0 | — | — | 0.0 | View |
| Jul 15, 2026 | NUVL | Balcom Alexandra | Chief Financial Officer | D | D (Sell) | 8,016.0 | — | — | 0.0 | View |
| Jul 15, 2026 | NUVL | Balcom Alexandra | Chief Financial Officer | D | D (Sell) | 131,637.0 | — | — | 0.0 | View |
| Jul 15, 2026 | NUVL | Balcom Alexandra | Chief Financial Officer | D | D (Sell) | 14,350.0 | — | — | 0.0 | View |
| Jul 15, 2026 | NUVL | Balcom Alexandra | Chief Financial Officer | A | A (Buy) | 14,350.0 | 0.0 | 0.0 | 14,350.0 | View |
| Jul 15, 2026 | NUVL | Balcom Alexandra | Chief Financial Officer | D | D (Sell) | 41,100.0 | — | — | 0.0 | View |
| Jul 15, 2026 | NUVL | Balcom Alexandra | Chief Financial Officer | U | D (Sell) | 44,433.0 | 124.0 | 5,509,692.0 | 0.0 | View |
| Jul 15, 2026 | NUVL | Srivastava Sapna | — | D | D (Sell) | 4,147.0 | — | — | 0.0 | View |
| Jul 15, 2026 | NUVL | Srivastava Sapna | — | D | D (Sell) | 3,789.0 | — | — | 0.0 | View |
| Jul 15, 2026 | NUVL | Srivastava Sapna | — | D | D (Sell) | 15,000.0 | — | — | 0.0 | View |
| Jul 15, 2026 | NUVL | Srivastava Sapna | — | D | D (Sell) | 20,000.0 | — | — | 0.0 | View |
| Jul 15, 2026 | NUVL | Srivastava Sapna | — | D | D (Sell) | 68,500.0 | — | — | 0.0 | View |
| Jul 15, 2026 | NUVL | Srivastava Sapna | — | D | D (Sell) | 3,444.0 | — | — | 0.0 | View |
| Jul 15, 2026 | NUVL | Srivastava Sapna | — | U | D (Sell) | 5,146.0 | 124.0 | 638,104.0 | 0.0 | View |
| Jul 15, 2026 | NUVL | Oliger Christy J. | — | D | D (Sell) | 6,119.0 | — | — | 0.0 | View |
| Jul 15, 2026 | NUVL | Oliger Christy J. | — | D | D (Sell) | 6,091.0 | — | — | 0.0 | View |
| Jul 15, 2026 | NUVL | Oliger Christy J. | — | U | D (Sell) | 1,324.0 | 124.0 | 164,176.0 | 0.0 | View |
| Jul 15, 2026 | NUVL | Squarer Ron | — | D | D (Sell) | 4,418.0 | — | — | 0.0 | View |
| Jul 15, 2026 | NUVL | Squarer Ron | — | D | D (Sell) | 6,281.0 | — | — | 0.0 | View |
| Jul 15, 2026 | NUVL | Turner Christopher Durant | Chief Medical Officer | D | D (Sell) | 17,500.0 | — | — | 0.0 | View |
| Jul 15, 2026 | NUVL | Turner Christopher Durant | Chief Medical Officer | D | D (Sell) | 37,500.0 | — | — | 0.0 | View |
| Jul 15, 2026 | NUVL | Turner Christopher Durant | Chief Medical Officer | D | D (Sell) | 47,500.0 | — | — | 0.0 | View |
| Jul 15, 2026 | NUVL | Turner Christopher Durant | Chief Medical Officer | D | D (Sell) | 144,200.0 | — | — | 0.0 | View |
| Jul 15, 2026 | NUVL | Turner Christopher Durant | Chief Medical Officer | D | D (Sell) | 107,000.0 | — | — | 0.0 | View |
| Jul 15, 2026 | NUVL | Turner Christopher Durant | Chief Medical Officer | D | D (Sell) | 2,835.0 | — | — | 0.0 | View |
| Jul 15, 2026 | NUVL | Turner Christopher Durant | Chief Medical Officer | D | D (Sell) | 303,105.0 | — | — | 0.0 | View |
| Jul 15, 2026 | NUVL | Turner Christopher Durant | Chief Medical Officer | D | D (Sell) | 14,350.0 | — | — | 0.0 | View |
| Jul 15, 2026 | NUVL | Turner Christopher Durant | Chief Medical Officer | A | A (Buy) | 14,350.0 | 0.0 | 0.0 | 14,350.0 | View |
| Jul 15, 2026 | NUVL | Turner Christopher Durant | Chief Medical Officer | D | D (Sell) | 41,100.0 | — | — | 0.0 | View |
| Jul 15, 2026 | NUVL | Turner Christopher Durant | Chief Medical Officer | U | D (Sell) | 31,530.0 | 124.0 | 3,909,720.0 | 0.0 | View |
| Jul 15, 2026 | NUVL | Noci Darlene | Chief Development Officer | D | D (Sell) | 17,500.0 | — | — | 0.0 | View |
| Jul 15, 2026 | NUVL | Noci Darlene | Chief Development Officer | D | D (Sell) | 37,500.0 | — | — | 0.0 | View |
| Jul 15, 2026 | NUVL | Noci Darlene | Chief Development Officer | D | D (Sell) | 33,646.0 | — | — | 0.0 | View |
| Jul 15, 2026 | NUVL | Noci Darlene | Chief Development Officer | D | D (Sell) | 81,329.0 | — | — | 0.0 | View |
| Jul 15, 2026 | NUVL | Noci Darlene | Chief Development Officer | D | D (Sell) | 21,259.0 | — | — | 0.0 | View |
| Jul 15, 2026 | NUVL | Noci Darlene | Chief Development Officer | D | D (Sell) | 15,112.0 | — | — | 0.0 | View |
| Jul 15, 2026 | NUVL | Noci Darlene | Chief Development Officer | D | D (Sell) | 6,091.0 | — | — | 0.0 | View |
| Jul 15, 2026 | NUVL | Noci Darlene | Chief Development Officer | D | D (Sell) | 216.0 | — | — | 0.0 | View |
| Jul 15, 2026 | NUVL | Noci Darlene | Chief Development Officer | D | D (Sell) | 14,350.0 | — | — | 0.0 | View |
| Jul 15, 2026 | NUVL | Noci Darlene | Chief Development Officer | A | A (Buy) | 14,350.0 | 0.0 | 0.0 | 14,350.0 | View |
| Jul 15, 2026 | NUVL | Noci Darlene | Chief Development Officer | D | D (Sell) | 41,100.0 | — | — | 0.0 | View |
| Jul 15, 2026 | NUVL | Noci Darlene | Chief Development Officer | U | D (Sell) | 17,017.0 | 124.0 | 2,110,108.0 | 0.0 | View |
| Jul 15, 2026 | NUVL | Lane Benjamin | See Remarks | D | D (Sell) | 19,000.0 | — | — | 0.0 | View |
| Jul 15, 2026 | NUVL | Lane Benjamin | See Remarks | D | D (Sell) | 8,000.0 | — | — | 0.0 | View |
| Jul 15, 2026 | NUVL | Lane Benjamin | See Remarks | D | D (Sell) | 12,025.0 | — | — | 0.0 | View |
| Jul 15, 2026 | NUVL | Lane Benjamin | See Remarks | D | D (Sell) | 15,052.0 | — | — | 0.0 | View |
| Jul 15, 2026 | NUVL | Lane Benjamin | See Remarks | D | D (Sell) | 17,848.0 | — | — | 0.0 | View |
| Jul 15, 2026 | NUVL | Lane Benjamin | See Remarks | D | D (Sell) | 8,333.0 | — | — | 0.0 | View |
| Jul 15, 2026 | NUVL | Lane Benjamin | See Remarks | D | D (Sell) | 731.0 | — | — | 0.0 | View |
| Jul 15, 2026 | NUVL | Lane Benjamin | See Remarks | D | D (Sell) | 7,120.0 | — | — | 0.0 | View |
| Jul 15, 2026 | NUVL | Lane Benjamin | See Remarks | A | A (Buy) | 7,120.0 | 0.0 | 0.0 | 7,120.0 | View |
| Jul 15, 2026 | NUVL | Lane Benjamin | See Remarks | D | D (Sell) | 29,433.0 | — | — | 0.0 | View |
| Jul 15, 2026 | NUVL | Lane Benjamin | See Remarks | U | D (Sell) | 21,092.0 | 124.0 | 2,615,408.0 | 0.0 | View |
| Jul 15, 2026 | NUVL | Pelish Henry E. | Chief Scientific Officer | D | D (Sell) | 17,500.0 | — | — | 0.0 | View |
| Jul 15, 2026 | NUVL | Pelish Henry E. | Chief Scientific Officer | D | D (Sell) | 37,500.0 | — | — | 0.0 | View |
| Jul 15, 2026 | NUVL | Pelish Henry E. | Chief Scientific Officer | D | D (Sell) | 18,600.0 | — | — | 0.0 | View |
| Jul 15, 2026 | NUVL | Pelish Henry E. | Chief Scientific Officer | D | D (Sell) | 21,073.0 | — | — | 0.0 | View |
| Jul 15, 2026 | NUVL | Pelish Henry E. | Chief Scientific Officer | D | D (Sell) | 9,900.0 | — | — | 0.0 | View |
| Jul 15, 2026 | NUVL | Pelish Henry E. | Chief Scientific Officer | D | D (Sell) | 8,309.0 | — | — | 0.0 | View |
| Jul 15, 2026 | NUVL | Pelish Henry E. | Chief Scientific Officer | D | D (Sell) | 2,113.0 | — | — | 0.0 | View |
| Jul 15, 2026 | NUVL | Pelish Henry E. | Chief Scientific Officer | D | D (Sell) | 3,258.0 | — | — | 0.0 | View |